{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T04:02:37Z","timestamp":1762747357376,"version":"3.43.0"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK118354"],"award-info":[{"award-number":["R01DK118354"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["12171329"],"award-info":[{"award-number":["12171329"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beijing Outstanding Young Scientist Program","award":["JWZQ20240101027"],"award-info":[{"award-number":["JWZQ20240101027"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:p>In clinical trials where long follow-up is required to measure the primary outcome of interest, there is substantial interest in using an accepted surrogate outcome that can be measured earlier in time or with less cost to estimate a treatment effect. For example, in clinical trials of chronic kidney disease, the effect of a treatment is often demonstrated on a longitudinal surrogate, the change of the longitudinal outcome (glomerular filtration rate, GFR) per year or GFR slope. However, estimating the effect of a treatment on the GFR slope is complicated by the fact that GFR measurement can be terminated by the occurrence of a terminal event, such as death or kidney failure. Thus, to estimate this effect, one must consider both the longitudinal GFR trajectory and the terminal event process. In this paper, we build a semiparametric framework to jointly model the longitudinal outcome and the terminal event, where the model for the longitudinal outcome is semiparametric, the relationship between the longitudinal outcome and the terminal event is nonparametric, and the terminal event is modeled via a semiparametric Cox model. The proposed semiparametric joint model is flexible and can be easily extended to include a nonlinear trajectory of the longitudinal outcome. An estimating equation\u00a0based method is proposed to estimate the treatment effect on the longitudinal surrogate outcome (eg, GFR slope). Theoretical properties of the proposed estimators are derived, and finite sample performance is evaluated through simulation studies. We illustrate the proposed method using data from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial to examine the effect of Losartan on GFR slope.<\/jats:p>","DOI":"10.1093\/biomtc\/ujaf104","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T15:31:57Z","timestamp":1754321517000},"source":"Crossref","is-referenced-by-count":1,"title":["Semiparametric joint modeling to estimate the treatment effect on a longitudinal surrogate with application to chronic kidney disease trials"],"prefix":"10.1093","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0011-5663","authenticated-orcid":false,"given":"Xuan","family":"Wang","sequence":"first","affiliation":[{"name":"University of Utah Division of Biostatistics, Department of Population Health Sciences, , Salt Lake City, UT 84108 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5061-4367","authenticated-orcid":false,"given":"Jie","family":"Zhou","sequence":"additional","affiliation":[{"name":"School of Mathematics, Capital Normal University , Beijing 100048 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7288-1009","authenticated-orcid":false,"given":"Layla","family":"Parast","sequence":"additional","affiliation":[{"name":"The University of Texas at Austin Department of Statistics and Data Sciences, , Austin, TX 78712 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Greene","sequence":"additional","affiliation":[{"name":"University of Utah Division of Biostatistics, Department of Population Health Sciences, , Salt Lake City, UT 84108 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,8,4]]},"reference":[{"key":"2025080411315131800_bib1","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/biom.13310","article-title":"Evaluation of longitudinal surrogate markers","volume":"77","author":"Agniel","year":"2021","journal-title":"Biometrics"},{"key":"2025080411315131800_bib2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S1062-1458(01)00549-9","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"1","author":"Brenner","year":"2002","journal-title":"ACC Current Journal Review"},{"key":"2025080411315131800_bib3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1146\/annurev-statistics-032921-035359","article-title":"Surrogate endpoints in clinical trials","volume":"10","author":"Elliott","year":"2023","journal-title":"Annual Review of Statistics and its Application"},{"article-title":"Table of surrogate endpoints that were the basis of drug approval or licensure","year":"2024","author":"FDA","key":"2025080411315131800_bib4"},{"volume-title":"DHARMa: Residual Diagnostics for Hierarchical (Multi-Level \/ Mixed) Regression Models","year":"2024","author":"Hartig","key":"2025080411315131800_bib5"},{"key":"2025080411315131800_bib6","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1038\/s41591-023-02418-0","article-title":"A meta-analysis of GFR slope as a surrogate endpoint for kidney failure","volume":"29","author":"Inker","year":"2023","journal-title":"Nature Medicine"},{"key":"2025080411315131800_bib7","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10985-006-9002-4","article-title":"Analysis of longitudinal health-related quality of life data with terminal events","volume":"12","author":"Jin","year":"2006","journal-title":"Lifetime Data Analysis"},{"key":"2025080411315131800_bib8","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/biostatistics\/kxi006","article-title":"Directly parameterized regression conditioning on being alive: analysis of longitudinal data truncated by deaths","volume":"6","author":"Kurland","year":"2005","journal-title":"Biostatistics"},{"key":"2025080411315131800_bib9","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1053\/j.ajkd.2011.12.009","article-title":"Longitudinal progression trajectory of GFR among patients with CKD","volume":"59","author":"Li","year":"2012","journal-title":"American Journal of Kidney Diseases"},{"key":"2025080411315131800_bib10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1198\/016214501750333018","article-title":"Semiparametric and nonparametric regression analysis of longitudinal data","volume":"96","author":"Lin","year":"2001","journal-title":"Journal of the American Statistical Association"},{"key":"2025080411315131800_bib11","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1002\/sim.6820","article-title":"Robust estimation of the proportion of treatment effect explained by surrogate marker information","volume":"35","author":"Parast","year":"2016","journal-title":"Statistics in Medicine"},{"key":"2025080411315131800_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v035.i09","article-title":"JM: An R package for the joint modelling of longitudinal and time-to-event data","volume":"35","author":"Rizopoulos","year":"2010","journal-title":"Journal of Statistical Software"},{"article-title":"The R package JMbayes for fitting joint models for longitudinal and time-to-event data using MCMC","year":"2014","author":"Rizopoulos","key":"2025080411315131800_bib13"},{"key":"2025080411315131800_bib14","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1177\/0962280217723675","article-title":"Interpretation of mixed models and marginal models with cohort attrition due to death and drop-out","volume":"28","author":"Rouanet","year":"2019","journal-title":"Statistical Methods in Medical Research"},{"key":"2025080411315131800_bib15","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511755453","volume-title":"Semiparametric Regression.\u00a0Number 12","author":"Ruppert","year":"2003"},{"key":"2025080411315131800_bib16","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1198\/016214505000000060","article-title":"Semiparametric regression analysis of longitudinal data with informative observation times","volume":"100","author":"Sun","year":"2005","journal-title":"Journal of the American Statistical Association"},{"key":"2025080411315131800_bib17","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1198\/016214507000000851","article-title":"Regression analysis of longitudinal data in the presence of informative observation and censoring times","volume":"102","author":"Sun","year":"2007","journal-title":"Journal of the American Statistical Association"},{"key":"2025080411315131800_bib18","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1080\/01621459.2012.682528","article-title":"Joint analysis of longitudinal data with informative observation times and a dependent terminal event","volume":"107","author":"Sun","year":"2012","journal-title":"Journal of the American Statistical Association"},{"key":"2025080411315131800_bib19","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1002\/sim.8282","article-title":"Mixed-effects models for slope-based endpoints in clinical trials of chronic kidney disease","volume":"38","author":"Vonesh","year":"2019","journal-title":"Statistics in Medicine"},{"key":"2025080411315131800_bib20","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/sim.2249","article-title":"Shared parameter models for the joint analysis of longitudinal data and event times","volume":"25","author":"Vonesh","year":"2006","journal-title":"Statistics in Medicine"},{"key":"2025080411315131800_bib21","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/biomet\/asz065","article-title":"Model-free approach to quantifying the proportion of treatment effect explained by a surrogate marker","volume":"107","author":"Wang","year":"2020","journal-title":"Biometrika"},{"volume-title":"All of Nonparametric Statistics","year":"2006","author":"Wasserman","key":"2025080411315131800_bib22"},{"key":"2025080411315131800_bib23","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1053\/j.ajkd.2016.02.039","article-title":"Estimated GFR trajectories of people entering CKD stage 4 and subsequent kidney disease outcomes and mortality","volume":"68","author":"Xie","year":"2016","journal-title":"American Journal of Kidney Diseases"}],"container-title":["Biometrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/biometrics\/article-pdf\/81\/3\/ujaf104\/63939294\/ujaf104.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/biometrics\/article-pdf\/81\/3\/ujaf104\/63939294\/ujaf104.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T15:32:01Z","timestamp":1754321521000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/biometrics\/article\/doi\/10.1093\/biomtc\/ujaf104\/8221846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,3]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,7,3]]}},"URL":"https:\/\/doi.org\/10.1093\/biomtc\/ujaf104","relation":{},"ISSN":["0006-341X","1541-0420"],"issn-type":[{"type":"print","value":"0006-341X"},{"type":"electronic","value":"1541-0420"}],"subject":[],"published-other":{"date-parts":[[2025,9]]},"published":{"date-parts":[[2025,7,3]]},"article-number":"ujaf104"}}